HSCT Remains Standard in Childhood ALL, Despite CAR T-Cells

08:40 EDT 26 Mar 2019 | Medscape

Clinicians should continue to rely on matched donor stem cell transplants to treat childhood acute lymphoblastic leukemia, while more data on novel CAR T-cell therapies is gathered, says German expert.
Medscape Medical News

Original Article: HSCT Remains Standard in Childhood ALL, Despite CAR T-Cells


More From BioPortfolio on "HSCT Remains Standard in Childhood ALL, Despite CAR T-Cells"

Quick Search


Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...